Startups
BioSimulytics Limited is a spin-out company founded in 2019 from the School of Chemical & Bioprocess Engineering of University College Dublin (UCD) in Ireland. The company is specialising in the deployment of Artificial Intelligence (AI) using advanced neural network technology, combined with molecular modelling, quantum physics and high performance computing, for the digitisation of next-generation drug development in the pharma/biotech sector, helping to unlock new and improved therapies faster and more cost efficiently, in order to address the pressing healthcare needs of society. The company’s particular niche lies in accurately and rapidly predicting the full panoply of ways in which API molecules arrange themselves in the solid, crystalline state – polymorphism – which is a well-known and continuing major challenge for the pharmaceutical industry. The technology can also be applied to predicting the most stable binding poses in protein-ligand complexes in the arena of structure-based drug design (SBDD).
Overview
Location
Ireland, Leinster, Dublin
Employees
1-10
Total raised
$712.18K
Founded date
2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 19, 2024 | Which Irish AI Startups are Making a Global Impact in 2023? | Artificial Intelligence (AI) has been a hot topic in the tech world for some time now. This advanced technology, which attempts to simulate human intelligence, is rapidly evolving and expanding its reach across a variety of industries. Unsu... |
| Jun 20, 2023 | Four innovative Irish medical start-ups granted €18m in EU funding | Irish medical start-ups, backed by Enterprise Ireland, Luminate Medical, Hooke Bio, BioSimulytics, and Celtic Biotech have won €18m in funding under the European Commission’s European Innovation Council (EIC) Accelerator Programme. Irish co... |
| Sep 3, 2021 | BioSimulytics Raises €600k For Drug Molecule Software | UCD software spinout BioSimulytics has secured €600,000 in initial seed funding for its software solution that uses artificial intelligence to transform success rates when developing new drugs. The NovaUCD-based company, founded in 2019 by ... |
Reviews 0
FAQ about BioSimulytics Limited
When was BioSimulytics Limited founded?
BioSimulytics Limited was founded in 2019.
How much funding has BioSimulytics Limited raised?
BioSimulytics Limited has raised $712.18K in total across 1 funding round.
What has the press written about BioSimulytics Limited?
Parsers VC has collected 4 articles mentioning BioSimulytics Limited, among them “Which Irish AI Startups are Making a Global Impact in 2023?” (Jan 19, 2024) and “Four innovative Irish medical start-ups granted €18m in EU funding” (Jun 20, 2023).
Is BioSimulytics Limited still active?
Yes, BioSimulytics Limited is active; its latest activity on Parsers VC dates from Jan 22, 2024.